We are delighted that LS CancerDiag is being featured in this digital booklet on Finnish expertise in cancer research and care! You can access or download the PDF version of the booklet here.
The publication lists many of the reasons, why Finland is a leading country in cancer research, such as its healthcare system which is one of the most efficient in the world – offering high value for money spent. It consists of highly educated professionals driving the growth of cutting-edge research and treatment in specialist areas, such as cancer and genetics research.
We are proud of our long-standing collaboration with the Helsinki University Hospital (HUS), which has been key in the development of our DiagMMR® assay and which according to the authors is recognized as a world leader in cancer research and care. As the first hospital in northern Europe awarded the Comprehensive Cancer Centre (CCC) accreditation by the Organization of European Cancer Institutes (OECI), HUS has developed into a nexus of cutting-edge medical research and treatment.